Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Jóna I[au]:

Lanthanides Report Calcium Sensor in the Vestibule of Ryanodine Receptor. Sárközi S et al. Biophys J. (2017)

Effects of fluvastatin and coenzyme Q10 on skeletal muscle in normo- and hypercholesterolaemic rats. Vincze J et al. J Muscle Res Cell Motil. (2015)

Laser induced calcium oscillations in fluorescent calcium imaging. Vincze J et al. Gen Physiol Biophys. (2018)

Search results

Items: 1 to 50 of 73

1.

Dantrolene Requires Mg2+ and ATP To Inhibit the Ryanodine Receptor.

Diszházi G, Magyar ZÉ, Mótyán JA, Csernoch L, Jóna I, Nánási PP, Almássy J.

Mol Pharmacol. 2019 Sep;96(3):401-407. doi: 10.1124/mol.119.116475. Epub 2019 Jul 23.

PMID:
31337666
2.

Laser induced calcium oscillations in fluorescent calcium imaging.

Vincze J, Geyer N, Diszházi G, Csernoch L, Bíró T, Jóna I, Dienes B, Almássy J.

Gen Physiol Biophys. 2018 May;37(3):253-261. doi: 10.4149/gpb_2017054. Epub 2018 Mar 28.

PMID:
29589836
3.

Lanthanides Report Calcium Sensor in the Vestibule of Ryanodine Receptor.

Sárközi S, Komáromi I, Jóna I, Almássy J.

Biophys J. 2017 May 23;112(10):2127-2137. doi: 10.1016/j.bpj.2017.03.023.

4.

Bile acids activate ryanodine receptors in pancreatic acinar cells via a direct allosteric mechanism.

Geyer N, Diszházi G, Csernoch L, Jóna I, Almássy J.

Cell Calcium. 2015 Aug;58(2):160-70. doi: 10.1016/j.ceca.2015.03.009. Epub 2015 Apr 17.

PMID:
25931303
5.

Effects of fluvastatin and coenzyme Q10 on skeletal muscle in normo- and hypercholesterolaemic rats.

Vincze J, Jenes Á, Füzi M, Almássy J, Németh R, Szigeti G, Dienes B, Gaál Z, Szentesi P, Jóna I, Kertai P, Paragh G, Csernoch L.

J Muscle Res Cell Motil. 2015 Jun;36(3):263-74. doi: 10.1007/s10974-015-9413-5. Epub 2015 Apr 29.

PMID:
25920381
6.

Synthesis of fluorescent ristocetin aglycon derivatives with remarkable antibacterial and antiviral activities.

Sipos A, Máté G, Rőth E, Borbás A, Batta G, Bereczki I, Kéki S, Jóna I, Ostorházi E, Rozgonyi F, Vanderlinden E, Naesens L, Herczegh P.

Eur J Med Chem. 2012 Dec;58:361-7. doi: 10.1016/j.ejmech.2012.10.030. Epub 2012 Oct 25.

PMID:
23149298
7.

Altered sarcoplasmic reticulum calcium transport in the presence of the heavy metal chelator TPEN.

Sztretye M, Almássy J, Deli T, Szentesi P, Jung C, Dienes B, Simut CA, Niggli E, Jona I, Csernoch L.

Cell Calcium. 2009 Nov-Dec;46(5-6):347-55. doi: 10.1016/j.ceca.2009.10.002. Epub 2009 Nov 8.

PMID:
19900703
8.

Effects of articaine and ropivacaine on calcium handling and contractility in canine ventricular myocardium.

Szentandrássy N, Szabó A, Almássy J, Jóna I, Horváth B, Szabó G, Bányász T, Márton I, Nánási PP, Magyar J.

Eur J Anaesthesiol. 2010 Feb;27(2):153-61. doi: 10.1097/EJA.0b013e328331a37b.

PMID:
19809324
9.

Charged surface area of maurocalcine determines its interaction with the skeletal ryanodine receptor.

Lukács B, Sztretye M, Almássy J, Sárközi S, Dienes B, Mabrouk K, Simut C, Szabó L, Szentesi P, De Waard M, Ronjat M, Jóna I, Csernoch L.

Biophys J. 2008 Oct;95(7):3497-509. doi: 10.1529/biophysj.107.120840. Epub 2008 Jul 11.

10.

Effects of K-201 on the calcium pump and calcium release channel of rat skeletal muscle.

Almassy J, Sztretye M, Lukacs B, Dienes B, Szabo L, Szentesi P, Vassort G, Csernoch L, Jona I.

Pflugers Arch. 2008 Oct;457(1):171-83. doi: 10.1007/s00424-008-0504-7. Epub 2008 May 6.

PMID:
18458945
11.

The Na+/Ca2+ exchange blocker SEA0400 fails to enhance cytosolic Ca2+ transient and contractility in canine ventricular cardiomyocytes.

Birinyi P, Tóth A, Jóna I, Acsai K, Almássy J, Nagy N, Prorok J, Gherasim I, Papp Z, Hertelendi Z, Szentandrássy N, Bányász T, Fülöp F, Papp JG, Varró A, Nánási PP, Magyar J.

Cardiovasc Res. 2008 Jun 1;78(3):476-84. doi: 10.1093/cvr/cvn031. Epub 2008 Feb 5.

PMID:
18252759
12.

Effect of natural phenol derivatives on skeletal type sarcoplasmic reticulum Ca2+ -ATPase and ryanodine receptor.

Sárközi S, Almássy J, Lukács B, Dobrosi N, Nagy G, Jóna I.

J Muscle Res Cell Motil. 2007;28(2-3):167-74. Epub 2007 Jul 20.

PMID:
17641978
13.

Alterations in the calcium homeostasis of skeletal muscle from postmyocardial infarcted rats.

Szigeti GP, Almássy J, Sztretye M, Dienes B, Szabó L, Szentesi P, Vassort G, Sárközi S, Csernoch L, Jóna I.

Pflugers Arch. 2007 Dec;455(3):541-53. Epub 2007 Jun 9.

PMID:
17558517
14.

Maurocalcine interacts with the cardiac ryanodine receptor without inducing channel modification.

Altafaj X, France J, Almassy J, Jona I, Rossi D, Sorrentino V, Mabrouk K, De Waard M, Ronjat M.

Biochem J. 2007 Sep 1;406(2):309-15.

15.

A riboswitch selective for the queuosine precursor preQ1 contains an unusually small aptamer domain.

Roth A, Winkler WC, Regulski EE, Lee BW, Lim J, Jona I, Barrick JE, Ritwik A, Kim JN, Welz R, Iwata-Reuyl D, Breaker RR.

Nat Struct Mol Biol. 2007 Apr;14(4):308-17. Epub 2007 Mar 25.

PMID:
17384645
16.

Ca2+ release from the sarcoplasmic reticulum activated by the low affinity Ca2+ chelator TPEN in ventricular myocytes.

Jung C, Zima AV, Szentesi P, Jona I, Blatter LA, Niggli E.

Cell Calcium. 2007 Feb;41(2):187-94. Epub 2006 Aug 22.

PMID:
16920191
17.

Insights into the regulation of the ryanodine receptor: differential effects of Mg2+ and Ca2+ on ATP binding.

Dias JM, Szegedi C, Jóna I, Vogel PD.

Biochemistry. 2006 Aug 8;45(31):9408-15.

PMID:
16878975
18.

Cardiomyopathies and sudden cardiac death caused by RyR2 mutations: are the channels the beginning and the end?

Jóna I, Nánási PP.

Cardiovasc Res. 2006 Aug 1;71(3):416-8. Epub 2006 Jun 9. No abstract available.

PMID:
16828071
19.

Characteristics of the glmS ribozyme suggest only structural roles for divalent metal ions.

Roth A, Nahvi A, Lee M, Jona I, Breaker RR.

RNA. 2006 Apr;12(4):607-19. Epub 2006 Feb 16.

20.

Effect of gadolinium on the ryanodine receptor/sarcoplasmic reticulum calcium release channel of skeletal muscle.

Sárközi S, Szegedi C, Lukács B, Ronjat M, Jóna I.

FEBS J. 2005 Jan;272(2):464-71.

21.

Modulation of sarcoplasmic reticulum function by Na+/K+ pump inhibitors with different toxicity: digoxin and PST2744 [(E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride].

Rocchetti M, Besana A, Mostacciuolo G, Micheletti R, Ferrari P, Sarkozi S, Szegedi C, Jona I, Zaza A.

J Pharmacol Exp Ther. 2005 Apr;313(1):207-15. Epub 2004 Dec 2.

PMID:
15576469
22.

New RNA motifs suggest an expanded scope for riboswitches in bacterial genetic control.

Barrick JE, Corbino KA, Winkler WC, Nahvi A, Mandal M, Collins J, Lee M, Roth A, Sudarsan N, Jona I, Wickiser JK, Breaker RR.

Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6421-6. Epub 2004 Apr 19.

23.

Altered elementary calcium release events and enhanced calcium release by thymol in rat skeletal muscle.

Szentesi P, Szappanos H, Szegedi C, Gönczi M, Jona I, Cseri J, Kovács L, Csernoch L.

Biophys J. 2004 Mar;86(3):1436-53.

24.

Effect of thymol on calcium handling in mammalian ventricular myocardium.

Szentandrássy N, Szigeti G, Szegedi C, Sárközi S, Magyar J, Bányász T, Csernoch L, Kovács L, Nánási PP, Jóna I.

Life Sci. 2004 Jan 2;74(7):909-21.

PMID:
14659979
25.

Critical amino acid residues determine the binding affinity and the Ca2+ release efficacy of maurocalcine in skeletal muscle cells.

Estève E, Smida-Rezgui S, Sarkozi S, Szegedi C, Regaya I, Chen L, Altafaj X, Rochat H, Allen P, Pessah IN, Marty I, Sabatier JM, Jona I, De Waard M, Ronjat M.

J Biol Chem. 2003 Sep 26;278(39):37822-31. Epub 2003 Jul 17.

26.

Troponin I converts the skeletal muscle ryanodine receptor into a rectifying calcium release channel.

Varsányi M, Sárközi S, Szegedi C, Herzog A, Jóna I.

FEBS Lett. 2002 Mar 27;515(1-3):155-8.

27.

FKBP12 modulation of the binding of the skeletal ryanodine receptor onto the II-III loop of the dihydropyridine receptor.

O'Reilly FM, Robert M, Jona I, Szegedi C, Albrieux M, Geib S, De Waard M, Villaz M, Ronjat M.

Biophys J. 2002 Jan;82(1 Pt 1):145-55.

28.

Effects of dantrolene on steps of excitation-contraction coupling in mammalian skeletal muscle fibers.

Szentesi P, Collet C, Sárközi S, Szegedi C, Jona I, Jacquemond V, Kovács L, Csernoch L.

J Gen Physiol. 2001 Oct;118(4):355-75.

29.

Skeletal and cardiac ryanodine receptors bind to the Ca(2+)-sensor region of dihydropyridine receptor alpha(1C) subunit.

Mouton J, Ronjat M, Jona I, Villaz M, Feltz A, Maulet Y.

FEBS Lett. 2001 Sep 21;505(3):441-4.

30.

Altered inhibition of the rat skeletal ryanodine receptor/calcium release channel by magnesium in the presence of ATP.

Jóna I, Szegedi C, Sárközi S, Szentesi P, Csernoch L, Kovács L.

Pflugers Arch. 2001 Mar;441(6):729-38.

PMID:
11316255
31.

Regulation of the rat sarcoplasmic reticulum calcium release channel by calcium.

Sárközi S, Szegedi C, Szentesi P, Csernoch L, Kovács L, Jóna I.

J Muscle Res Cell Motil. 2000 Feb;21(2):131-8.

PMID:
10961837
32.
33.

Biphasic effect of bimoclomol on calcium handling in mammalian ventricular myocardium.

Nánási PP, Sárközi S, Szigeti G, Jóna I, Szegedi C, Szabó A, Bányász T, Magyar J, Szigligeti P, Körtvély A, Csernoch L, Kovács L, Jednákovits A.

Br J Pharmacol. 2000 Apr;129(7):1405-12.

34.

Effects of tetracaine on sarcoplasmic calcium release in mammalian skeletal muscle fibres.

Csernoch L, Szentesi P, Sárközi S, Szegedi C, Jona I, Kovács L.

J Physiol. 1999 Mar 15;515 ( Pt 3):843-57.

35.

Calsequestrin: more than 'only' a luminal Ca2+ buffer inside the sarcoplasmic reticulum.

Szegedi C, Sárközi S, Herzog A, Jóna I, Varsányi M.

Biochem J. 1999 Jan 1;337 ( Pt 1):19-22.

36.

Effects of cardiac glycosides on excitation-contraction coupling in frog skeletal muscle fibres.

Sárközi S, Szentesi P, Jona I, Csernoch L.

J Physiol. 1996 Sep 15;495 ( Pt 3):611-26.

37.
38.

Sarcolipin, the "proteolipid" of skeletal muscle sarcoplasmic reticulum, is a unique, amphipathic, 31-residue peptide.

Wawrzynow A, Theibert JL, Murphy C, Jona I, Martonosi A, Collins JH.

Arch Biochem Biophys. 1992 Nov 1;298(2):620-3.

PMID:
1416990
40.

Effects of pH, Ca2+ and lanthanides on conformation of the sarcoplasmic reticulum Ca(2+)-ATPase catalytic site.

Ivkova MN, Pletnev VV, Vinokurov MG, Pechatnikov VA, Ivkov VG, Jona I, Fölöp J, Köver A.

Biochim Biophys Acta. 1992 Feb 1;1118(3):231-8.

PMID:
1531300
41.

Immunological relatedness of the sarcoplasmic reticulum Ca(2+)-ATPase and the Na+,K(+)-ATPase.

Molnar E, Varga S, Jona I, Seidler NW, Martonosi A.

Biochim Biophys Acta. 1992 Jan 31;1103(2):281-95.

PMID:
1371934
42.
43.

Ca2+ release from caged-Ca2+ alters the FTIR spectrum of sarcoplasmic reticulum.

Buchet R, Jona I, Martonosi A.

Biochim Biophys Acta. 1991 Nov 4;1069(2):209-17.

PMID:
1834174
44.

Covalent labeling of the cytoplasmic or luminal domains of the sarcoplasmic reticulum Ca(2+)-ATPase with fluorescent azido dyes.

Molnar E, Varga S, Jona I, Martonosi A.

Biochim Biophys Acta. 1991 Sep 10;1068(1):27-40.

PMID:
1832561
45.
46.

Emerging views on the structure and dynamics of the Ca2(+)-ATPase in sarcoplasmic reticulum.

Martonosi AN, Jona I, Molnar E, Seidler NW, Buchet R, Varga S.

FEBS Lett. 1990 Aug 1;268(2):365-70. Review.

47.
48.

Pressure effects on sarcoplasmic reticulum: a Fourier transform infrared spectroscopic study.

Buchet R, Carrier D, Wong PT, Jona I, Martonosi A.

Biochim Biophys Acta. 1990 Mar 30;1023(1):107-18.

PMID:
2138499
49.

Cyclopiazonic acid is a specific inhibitor of the Ca2+-ATPase of sarcoplasmic reticulum.

Seidler NW, Jona I, Vegh M, Martonosi A.

J Biol Chem. 1989 Oct 25;264(30):17816-23.

50.

Effect of calcium on the interactions between Ca2+-ATPase molecules in sarcoplasmic reticulum.

Keresztes T, Jona I, Pikula S, Vegh M, Mullner N, Papp S, Martonosi A.

Biochim Biophys Acta. 1989 Sep 18;984(3):326-38.

PMID:
2550078

Supplemental Content

Support Center